TickerFacts.

Bio Essence Corp (BIOE): Long-Term Debt

Annual figures by period end, from SEC filings.

$57.5K
As of 2025-12-31
$56.8K
As of 2026-06-30
2024-12-31: $56.5K2025-12-31: $57.5K$57.5K
2024-12-31 Long-Term Debt (USD) 2025-12-31
Period endedLong-Term DebtChange YoYSource filing
2025-12-31$57.5K+1.8%2026-03-27, Balance as of period end
2024-12-31$56.5Kn/a2025-03-28, Balance as of period end

Long-Term Debt at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedLong-Term DebtChange YoY
Bio Essence Corp (BIOE)2025-12-31$57.5K+1.8%
Rani Therapeutics Holdings, Inc. (RANI)2024-12-31$25.00M-16.7%
Northwest Biotherapeutics Inc (NWBO)2025-12-31$60.04M-4.2%
China SXT Pharmaceuticals, Inc. (SXTC)2025-03-31$807.2K+27.8%
60 Degrees Pharmaceuticals, Inc. (SXTP)2025-12-31$150.0K0.0%
BioXcel Therapeutics, Inc. (BTAIQ)2025-12-31$109.59M+6.9%
Yarrow Bioscience, Inc. (YARW)2025-12-31$0n/a
Scienture Holdings, Inc. (SCNX)2024-12-31$2.90Mn/a
BioAge Labs, Inc. (BIOA)2024-12-31$8.50Mn/a

Compare BIOE, RANI, NWBO, SXTC side by side · Screen every company in Pharmaceutical Preparations ↗